Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.24.0.1
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 133,053 $ 146,999
Trading account assets, pledged as collateral 130,815 115,505
Debt securities:    
Fair Value 496,597 524,267
Loans and leases, measured at fair value 3,569 5,771
Loans held for sale, measured at fair value 2,059 1,115
Other assets, measured at fair value 11,861 9,594
Deposits in U.S. offices:    
Interest bearing, measured at fair value 284 311
Federal funds purchased and securities loans or sold under agreements to repurchase, at fair value 178,609 151,708
Short-term borrowings, measured at fair value 4,690 832
Accrued expenses and other liabilities, measured at fair value 11,473 9,752
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,209 1,540
Long-term debt, measured at fair value $ 42,809 $ 33,070
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 4,088,099 4,088,101
Preferred stock outstanding (in shares) 4,088,099 4,088,101
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 7,895,457,665 7,996,777,943
Common stock outstanding (in shares) 7,895,457,665 7,996,777,943
Short-term borrowings $ 32,098 $ 26,932
Long-term debt 302,204 275,982
Consolidated VIEs    
Shareholders’ equity    
Short-term borrowings 2,957 42
Long-term debt 8,456 4,581
All other liabilities 19 13
Consolidated VIEs | Nonrecourse    
Shareholders’ equity    
Short-term borrowings 23 42
Long-term debt 8,456 4,581
All other liabilities $ 19 $ 13